Latest Breaking News On - Valency communications - Page 2 : comparemela.com

Mendus to participate in multiple investor and industry conferences in September

Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced its participation in the following upcoming investor and industry conferences: H.C. Wainwright 25th Annual Global Investment Conference New York, USA, September 11-13, 2023 Mendus CEO Erik Manting will participate and present a Company Update at the conference: https://hcwevents.com/annualconference/ Pareto Securities' Annual Healthcare Conference Stockholm, Swe

United statesNew yorkErik mantingCorey davisMario brkuljHans preustingLotta fermLifesci advisorsInternational cancer immunotherapy conferenceValency communicationsAnnual global investmentCompany updateOpening ceremonyNorthx innovationNasdaq stockholmSci advisors

Change in number of shares and votes in Mendus AB (publ)

As previously announced Mendus AB has carried out a capital raise whereby 472,953,859 new shares were issued in a rights issue and 187,500,000 new shares were issued in a directed issue. As a.

Erik mantingCorey davisMario brkuljValency communicationsLifesci advisorsSwedish financial instruments trading actNasdaq stockholmSci advisors

Mendus AB (publ) Interim Report January – June 2023

Mendus AB (publ) Interim Report January – June 2023
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesLewis lanierMario brkuljErik mantingCorey davisEuropean medicines agencyNegma groupValency communicationsLifesci advisorsAmerican association for cancer researchNorthx biologicsAmerican associationCancer researchScientific advisoryAnnual reportAnnual general meeting

Mendus publishes preclinical data demonstrating synergies of ilixadencel and 4-1BB-targeting immunotherapies

Mendus publishes preclinical data demonstrating synergies of ilixadencel and 4-1BB-targeting immunotherapies
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

Uppsala lanAlex karlsson parraCorey davisErik mantingMario brkuljValency communicationsDepartment of immunologyUppsala universityLifesci advisorsChief scientific officerNasdaq stockholmSci advisors

Mendus raises approximately SEK 317 million through the directed issue to Flerie and a fully secured rights issue

Mendus raises approximately SEK 317 million through the directed issue to Flerie and a fully secured rights issue
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSouth koreaEastern capeSouth africaHong kongUnited kingdomNew zealandCorey davisMario brkuljBaker mckenzie advokatbyrErik mantingSwedish financial supervisory authorityEuropean parliamentLifesci advisorsSwedish companies registration officeCommission delegated directive